INTRODUCTION: American Indians have the highest smoking rates in the United States, yet few randomized controlled trials of culturally specific interventions exist. This study assessed American Indians' opinions about evidence-based treatment and attitudes toward participating in clinical trials. METHODS:Six focus groups were conducted based on smoking status (current/former smoker), sex, and elder status (55 years and older or younger). Meetings were held at local American Indian community organizations. This project was accomplished in partnership with the American Indian Community Tobacco Projects, a community-academic research partnership at the University of Minnesota. Thematic qualitative data analyses were conducted. RESULTS: Participants desired the following: (a) programs led by trained American Indian community members, (b) the opportunity to connect with other American Indian smokers interested in quitting, and (c) programs promoting healthy lifestyles. Strategies desired for treatment included (a) free pharmacotherapy, including nicotine replacement therapy (NRT); (b) nominal incentives, e.g., gift cards for groceries; and (c) culturally specific program components such as American Indian images, education on traditional tobacco use, and quit-smoking messages that target the value of family and include narratives or story telling in recruitment and program materials. Biochemical verification of smoking abstinence, such as salivary cotinine or carbon monoxide breathalyzers, is likely acceptable. Standard treatment or delayed treatment control groups were viewed as potentially acceptable for randomized study designs. CONCLUSIONS: Rigorously conducted randomized controlled trials of culturally specific smoking cessation interventions are sorely needed but will only be accomplished with the commitment of funders, researchers, and collaborative trusting relationships with the community.
RCT Entities:
INTRODUCTION: American Indians have the highest smoking rates in the United States, yet few randomized controlled trials of culturally specific interventions exist. This study assessed American Indians' opinions about evidence-based treatment and attitudes toward participating in clinical trials. METHODS: Six focus groups were conducted based on smoking status (current/former smoker), sex, and elder status (55 years and older or younger). Meetings were held at local American Indian community organizations. This project was accomplished in partnership with the American Indian Community Tobacco Projects, a community-academic research partnership at the University of Minnesota. Thematic qualitative data analyses were conducted. RESULTS:Participants desired the following: (a) programs led by trained American Indian community members, (b) the opportunity to connect with other American Indian smokers interested in quitting, and (c) programs promoting healthy lifestyles. Strategies desired for treatment included (a) free pharmacotherapy, including nicotine replacement therapy (NRT); (b) nominal incentives, e.g., gift cards for groceries; and (c) culturally specific program components such as American Indian images, education on traditional tobacco use, and quit-smoking messages that target the value of family and include narratives or story telling in recruitment and program materials. Biochemical verification of smoking abstinence, such as salivary cotinine or carbon monoxide breathalyzers, is likely acceptable. Standard treatment or delayed treatment control groups were viewed as potentially acceptable for randomized study designs. CONCLUSIONS: Rigorously conducted randomized controlled trials of culturally specific smoking cessation interventions are sorely needed but will only be accomplished with the commitment of funders, researchers, and collaborative trusting relationships with the community.
Authors: Jan Gryczynski; Robert Feldman; Olivia Carter-Pokras; Mariano Kanamori; Lu Chen; Susan Roth Journal: J Health Care Poor Underserved Date: 2010-05
Authors: Dale Bramley; Tania Riddell; Robyn Whittaker; Tim Corbett; Ruey-Bin Lin; Mary Wills; Mark Jones; Anthony Rodgers Journal: N Z Med J Date: 2005-06-03
Authors: Vanessa Johnston; Darren W Westphal; Marewa Glover; David P Thomas; Catherine Segan; Natalie Walker Journal: Nicotine Tob Res Date: 2013-03-21 Impact factor: 4.244
Authors: Patricia Nez Henderson; Shalini Kanekar; Yang Wen; Dedra Buchwald; Jack Goldberg; Won Choi; Kolawole S Okuyemi; Jasjit Ahluwalia; Jeffrey A Henderson Journal: Am J Public Health Date: 2009-11 Impact factor: 9.308
Authors: Diana Burgess; Steven S Fu; Anne M Joseph; Dorothy K Hatsukami; Jody Solomon; Michelle van Ryn Journal: Nicotine Tob Res Date: 2007-01 Impact factor: 4.244
Authors: Michelle DiGiacomo; Patricia M Davidson; Penelope A Abbott; Joyce Davison; Louise Moore; Sandra C Thompson Journal: Int J Environ Res Public Health Date: 2011-01-31 Impact factor: 3.390
Authors: Won S Choi; Laura A Beebe; Niaman Nazir; Baljit Kaur; Michelle Hopkins; Myrietta Talawyma; Theresa I Shireman; Hung-Wen Yeh; K Allen Greiner; Christine M Daley Journal: Am J Prev Med Date: 2016-07-18 Impact factor: 5.043
Authors: Craig N Sawchuk; Peter Roy-Byrne; Carolyn Noonan; Andy Bogart; Jack Goldberg; Spero M Manson; Dedra Buchwald Journal: Nicotine Tob Res Date: 2015-04-06 Impact factor: 4.244
Authors: Jummai Apata; Payam Sheikhattari; Lisa Bleich; Farin Kamangar; Anne Marie O'Keefe; Fernando A Wagner Journal: J Community Health Date: 2019-10
Authors: Jaedon P Avey; Vanessa Y Hiratsuka; Julie A Beans; Susan Brown Trinidad; Rachel F Tyndale; Renee F Robinson Journal: Pharmacogenomics Date: 2016-02-12 Impact factor: 2.533
Authors: Stevens S Smith; Leah M Rouse; Mark Caskey; Jodi Fossum; Rick Strickland; J Kevin Culhane; Jerry Waukau Journal: Couns Psychol Date: 2014-07-17
Authors: Ashley L Comiford; Dorothy A Rhoades; Paul Spicer; Kai Ding; Justin D Dvorak; Leslie Driskill; Theodore L Wagener; Mark P Doescher Journal: Am J Health Behav Date: 2018-11-01